CA2187094C - Rapid response occlusion detector for a medication infusion pump - Google Patents
Rapid response occlusion detector for a medication infusion pump Download PDFInfo
- Publication number
- CA2187094C CA2187094C CA002187094A CA2187094A CA2187094C CA 2187094 C CA2187094 C CA 2187094C CA 002187094 A CA002187094 A CA 002187094A CA 2187094 A CA2187094 A CA 2187094A CA 2187094 C CA2187094 C CA 2187094C
- Authority
- CA
- Canada
- Prior art keywords
- medication
- difference
- lead screw
- alarm
- administer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/16854—Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1456—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
An improved occlusion detector is provided in a medication infusion pump (10) to monitor medication delivery to a patient, and to provide an early alarm in the event of medication nondelivery. The detector comprises a force sensor (52) and related control circuit for reading and comparing the pressure applied to the medication at the time of pump operation to administer a dose to the patient, with the same pressure at a later point in time preceding the next dose. If a difference between the pressure readings is less than a predetermined value, an occlusion of the medication delivery line is indicated and an alarm is activated.
Description
WO 96/27398 ~ ' ~ pC1'IU596102199 S, -t -1-RAPID RESPONSE OCCLUSION DETECTOR
FOR A MEDICATION INFUSION PUMP
EACKGROUND OF THE INVENTION
This invention relates generally to improvements in infusion pumps of the type used for controlled delivery of medication to a patient. More specifically, this invention relates to an improved occlusion detector for use in a medication infusion pump, to provide an early alarm of medication nondelivery due to an occlusion along the medication delivery flow path or other pump drive system failure.
Infusion pump devices and systems are relatively well-known in the medical arts, for use in delivering or dispensing a prescribed medication such as insulin to a patient. In one form, such devices comprise a relatively compact pump housing adapted to receive a syringe carrying a prescribed medication for administration to a patient through infusion tubing and an associated catheter or the like. The infusion pump includes a small stepping drive motor having an output connected via a lead screw assembly for motor-driven advancement of a syringe piston plunger to administer the medication to the patient.
Programmable control means are normally provided for ' 'tiperating the drive motor at periodic intervals to obtain a closely controlled and accurate delivery of ' the medication over an extended time period. Such .. .. _ .".,.,~... _ _. _. _ ~_ ,.. "__, .
FOR A MEDICATION INFUSION PUMP
EACKGROUND OF THE INVENTION
This invention relates generally to improvements in infusion pumps of the type used for controlled delivery of medication to a patient. More specifically, this invention relates to an improved occlusion detector for use in a medication infusion pump, to provide an early alarm of medication nondelivery due to an occlusion along the medication delivery flow path or other pump drive system failure.
Infusion pump devices and systems are relatively well-known in the medical arts, for use in delivering or dispensing a prescribed medication such as insulin to a patient. In one form, such devices comprise a relatively compact pump housing adapted to receive a syringe carrying a prescribed medication for administration to a patient through infusion tubing and an associated catheter or the like. The infusion pump includes a small stepping drive motor having an output connected via a lead screw assembly for motor-driven advancement of a syringe piston plunger to administer the medication to the patient.
Programmable control means are normally provided for ' 'tiperating the drive motor at periodic intervals to obtain a closely controlled and accurate delivery of ' the medication over an extended time period. Such .. .. _ .".,.,~... _ _. _. _ ~_ ,.. "__, .
infusion pumps are utilized to administer insulin and other medications, with an exemplary pump construction being shown and described in U.S. Patent Nos. 4,562,751; 4,678,408; and 4,685,903.
Infusion pumps of the general type described above have provided significant advantages and benefits with respect to accurate delivery of medication over an extended time period. The infusion pump is often designed to be extremely compact and may thus be adapted to be carried by the patient, for example, by means of a belt clip or the like. As a result, important medication can be administered with precision and in an automated manner, without significant restriction on the patients -mobility or life-style.
In the past, medication infusion pumps have included alarm systems designed to detect and indicate pump malfunction and/or nondelivery of the medication to the patient as a result of an occluded delivery line. Such alarm systems have typically used a high pressure limit switch for activating an alarm when the force applied to the syringe piston plunger reaches a predetermined upper limit indicative of an occluded medication delivery line.
In U.S. Patent 4,562,751, the high pressure switch is positioned at one end of a rotatable lead screw, wherein the mechanical reaction force or backlash between the syringe plunger and the pressure switch is proportional to the pressure applied to the medication as a result of attempted advancement of the syringe plunger. In actual practice, however, such high pressure limit switches have not provided the desired early warning of an occlusion, but instead have required multiple consecutive nondelivered doses before the pressure will rise to a level sufficient to activate the high pressure WO 96!27398 PCTIUS96102199 f ' . ~,'~* _3_ 1f switch. For many patients, it may take several hours for the occurrence of several consecutive doses, whereby an occlusion may go undetected for an undesirably long period of time. This problem is especially significant when the patient is a child, and wherein each dose comprises a relatively small volume of the medication.
There exists, therefore, a significant need for further improvements in medication infusion pumps particularly with respect to improved and rapid response occlusion detection for providing an early warning of an occlusion or other pump drive system failure. The present invention fulfills this need and provides further related advantages.
&UMMARY OF THE INVENTION
In accordance with the invention, a medication infusion pump is provided with an improved occlusion detector for monitoring medication delivery to a patient, and to provide an early alarm in the event of medication nondelivery. The occlusion detector comprises a force sensor and a related control circuit for reading and comparing the pressure applied to the medication at specific points in time relative to pump operation to administer the medication, and for activating an appropriate alarm in the event that the monitored pressure readings indicate an occlusion of the medication delivery lin e.
In the preferred form, the medication infusion pump comprises a compact pump housing for receiving and supporting a syringe filled with a prescribed medication such as insulin for administration to a patient through infusion tubing and an associated catheter or the like. A small stepping drive motor within the pump housing is programmably operated at intervals to rotate a lead h ..:~.
". .~s:~~ .
., ~. , . . .. e'.
screw, resulting in precision translation of a lead screw nut coupled to the piston plunger of the medication-containing syringe. The piston plunger is thus advanced incrementally to deliver prescribed ' medication doses from the syringe and through the infusion tubing to the patient. ' The force sensor of the occlusion detector is mounted at one end of the lead screw in a position for monitoring the drive force applied to the syringe piston plunger. That is, said drive force is coupled by mechanical reaction or backlash through the lead screw for detection and monitoring by the force sensor. The force detected by the sensor is directly proportional to the pressure applied to the medication within the syringe.
The control circuit causes the force sensor to read the pressure substantially at the time of administering a medication dose to the patient, and again at a later time preceding the next dose. The control circuit compares these two pressure readings, to determine whether the infusion tubing and/or catheter are occluded. Specifically, if the difference between the two pressure readings is less than a predetermined value, an occlusion is indicated and an alarm is activated. Conversely, if the compared difference is greater than said predetermined value, then the pressure applied to the medication within the syringe has dropped to reflect actual and proper medication delivery to the patient.
Other features and advantages of the present invention will become more apparent from the following detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, the principles of the invention.
R'O 96/27398 ~~gg6102199 _5_ :., .;~:~,~;~094 BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings illustrate the invention. In such drawings:
FIGURE 1 is a front perspective view illustrating a medication infusion pump for controlled delivery of medication to a patient, and further adapted to include the rapid response occlusion detector embodying the novel features of the invention;
FIGURE 2 is an enlarged rear elevation view of the infusion pump of FIG. 1, with portions broken away to illustrate pump operating components;
FIGURE 3 is a schematic circuit diagram illustrating the occlusion detector; and FIGURE 4 is a schematic circuit diagram depicting an alternative preferred form of the invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
As shown in the exemplary drawings, a medication infusion pump referred to generally in FIGURE 1 by the reference numeral 10 is provided for controlled administration of medication to a patient. In accordance with the invention, the infusion pump 10 includes a rapid response occlusion detector for monitoring and verifying proper delivery of the medication to the patient.
The infusion pump 10 has an overall construction and operation which is generally known ' in the art. More specifically, with respect to FIGS.
1 and 2, the infusion pump 10 comprises a relatively ' compact pump housing 12 defining an elongated chamber 14 (FIG. 2) for receiving and supporting a syringe 16 charged with a selected medication, such as insulin, to be administered to a patient. - The medication R'O 96127398 ~~ , PCTIUS96/02199 a _6_ -, containing syringe 16 includes a syringe barrel 18 joined at the front to a luer neck 20 of reduced diametric size to seat snugly within an outlet port 22 formed in the pump housing 12. A luer fitting 24 is carried on the neck 20 and cooperates with the barrel 18 to fix the syringe in a seated position within the syringe chamber 14. A syringe piston or plunger 26 extends from the aft end of the barrel 18 and may be advanced into the barrel to deliver the medication therefrom. In this regard, the medication is normally dispensed to the patient through a catheter tube 28 or the like adapted for appropriate connection to the luer fitting 24.
The infusion pump 10 includes a compact stepping drive motor 30 (FIG. 2) which is mechanically connected to the syringe plunger 26 for purposes of advancing the plunger in a precision controlled manner to dispense the medication. In this regard, the drive motor 3o is normally powered by a battery power supply 32 or the like, in response to operation of a programmable controller 34. As known in the art, the programmable controller 34 can be set by the attending physician, appropriate medical personnel, or the user by an array of buttons 36 on the face or front of the pump housing 12, with a corresponding display panel 38 providing appropriate information regarding set status and/or pump operation. The controller 34 operates the drive motor 30 in a stepwise manner, typically on an intermittent basis, to administer discrete precision doses of the medication to the patient at programmed times. ' The mechanical connection between the stepping drive motor 30 and the syringe plunger 26 includes a lead screw assembly 40. More specifically, the drive motor 30 has a rotary output for rotatably driving an elongated lead screw 42 _7_ mounted within the pump housing 12. A lead screw nut 44 is carried on the lead screw 42 and includes an appropriate latch arm 46 for engaging a drive flange 48 on the end of the piston plunger 26. Appropriate rotation of the lead screw 42 in response to operation of the stepping motor 30, causes the lead screw nut 44 and associated latch arm 46 to be translated in a precision manner to correspondingly advance the piston plunger 26 and thereby deliver the medication from the syringe barrel 18 and through the catheter tube 28 to the patient. Further details regarding the construction and operation of a medication infusion pump of this general type can be found in U.S. Patent Nos. 4,562,571; 4,678,408: and 4,685,903, The occlusion detector of the present invention is designed to provide early warning of system malfunction, particularly nondelivery of a medication dose to the patient as a result of an occluded medication flow path. In this regard, in general terms, translation of the lead screw nut 44 and the latch arm 46 to deliver medication from the syringe 16, will be accompanied by a rise in pressure applied to the medication within the syringe barrel 18. During normal operation with proper medication delivery to the patient, that pressure rise will subside within a relatively short period of time, reflecting medication flow out of the syringe barrel 1B and through the catheter tube 28 to the patient.
Nowever, if the flow path is obstructed, the pressure rise will not subside to any substantial degree.
Consecutive attempts to administer medication to the patient will result in a stepwise increase in the pressure applied to the medication within the syringe barrel.
The occlusion detector of the present 'invention monitors the pressure applied to the medication at spaced-apart points in time, to determine whether an occluded flow line condition exists. If the pressure reading comparison is less than a predetermined value, indicative of little or no subsiding in medication pressure following a dispense event, then an occlusion condition is promptly detected so that an appropriate alarm 50 (FIGS. 3 and 4) such as an audible alarm can be activated. Conversely, if the monitored pressure difference exceeds the predetermined value, reflective of proper subsidence in pressure level over a period of time, then normal pump medication delivery is indicated.
The occlusion detector includes a force sensor 52 such as a variable resistor force sensor of the type marketed by Interlink Electronics of Camarillo, California, under the product designation FSR~: As shown best in FIG. 2, the force sensor 52 is mounted on the pump housing 12 at one end of the lead screw 42. The force sensor 52 is positioned to monitor an axial reaction or backlash force applied to the lead screw 42 via the piston plunger 26 and the associated lead screw nut 44, when the lead screw 42 is rotated upon attempted delivery of the medication to the patient. Accordingly, the force sensor 52 detects a force which is directly proportional to the pressure applied to the medication within the syringe barrel 18.
As shown in FIG. 3 in one preferred form, the force sensor 52 provides an input signal to a control circuit 54 which is coupled with the pump programmable controller 34. As shown, the control circuit 54 includes an interface amplifier 56 and an analog-to-digital converter 58 for conditioning the * Trademark R'O 96/27398 PCTIUS96102199 _9_ ;~~-8794 output signal of the force sensor 52 and for supplying that output signal to a microprocessor 60 for storage and subsequent processing functions.
The microprocessor 60 is operated by the controller 34 to read and store the force reading outputs from the force sensor 52 in a memory 62. These force readings are taken substantially at the time of medication administration to the patient, i.e., immediately after lead screw rotation to advance the position plunger 26, and at a later time shortly preceding the next dose. These readings are compared to provide an indication of proper medication delivery, or nondelivery, as described above.
More particularly, the pressure applied to the medication within the syringe barrel 18 is relatively high when the syringe plunger 26 is advanced during a delivery event. However, this pressure will subside relatively quickly if the medication delivery path is unobstructed, since the pressure will be relieved by delivery of the medication dose to the patient. Conversely, if the delivery path is occluded, the pressure applied to the medication will not subside to a substantial degree. Accordingly, by comparing the readings from the force sensor 52 during a delivery event and at a later time such as shortly before the next delivery event, accurate occlusion monitoring is obtained. If the compared readings exceed a predetermined level indicative of substantial subsiding of the pressure within the syringe barrel 18, then proper medication delivery is indicated. However, if the compared readings are the same or otherwise less than said predetermined level, then nondelivery attributable to ° an occluded flow path is indicated.
In the preferred form, to prevent false alarms, the controller 34 and microprocessor 60 can be set to require a minimum number of perhaps two to four consecutive detected occlusion events before activating the alarm 50. This number of nondelivered doses, however, can be sufficiently small in number to provide the desired early occlusion warning for juvenile patients.
In addition, the system can be programmed to provide other alarm functions, particularly such as detecting failure of the lead screw 42 to rotate in response to operation of the stepping motor 30. In this mode, the microprocessor 6~ reads force signals for the force sensor 52 immediately before and after stepping motor operation. If the monitored force signals are reflective of a pressure rise within the syringe barrel 18, in response to the desired advancement of the syringe plunger 26, then normal operation is indicated. However, if no pressure rise is detected by comparing these force readings, then the syringe plunger 26 has not been advanced as a result of some drive system failure, whereupon the alarm 50 can be activated.
A further safeguard is desirably included in the control circuit 54 to prevent false alarms during initial primary of the ,catheter tube 28. In this process, the controller 34 and microprocessor 60 are set to ignore pressure-indicative output signals from the force sensor 52 unless and until those signals exceed a predetermined low level threshold. That is, during normal operation with the tubing 2B primed, pressures below the low level threshold are not encountered.
FIGURE 4 illustrates one alternative form of the control circuit, wherein components corresponding functionally to those shown and described in FIG. 3 are identified by common primed reference numerals.
As shown, the force sensor 52' is coupled by an interface amplifier 56' to a switch logic circuit 60'. The programmable controller 34 operates the WO 96/27398 PCTlUS96102199 ::.
~~'~ 218 ~0 9 4 circuit 60' to 'read and store force reading's at a time substantially corresponding with medication delivery to the patient, and at a later time shortly preceding the next dosage, by appropriate opening and closure, respectively, of a pair of switches 65 and 66 for coupling these readings to the minus and plus inputs of a comparator 68. The force readings are compared by the comparator 68, and an appropriate alarm 50 is activated when the difference between the compared readings is less than a predetermined value indicative of an occlusion, as described previously with respect to FIG. 3. A variable resistor offset 70 is inputted to the comparator 68 to set the difference threshold required to activate the alarm.
In addition, a minimum force comparator circuit 72 is desirably provided to disable the comparator 68 when the detected force levels are sufficiently low to indicate a pump priming procedure.
The invention thus provides accurate and rapid response occlusion detection by monitoring pressure differentials at predetermined points in time relative to medication delivery events. With this approach, an occlusion condition or other drive system failure can be detected promptly, without requiring any significant number of consecutive delivery failures and a corresponding prolonged period of medication nondelivery to a patient. Rapid occlusion detection can be particularly important to those patients who receive medication doses of very small volumes, particularly patients such as children.
A variety of further modifications and improvements to the invention will be apparent to those skilled in the art. Accordingly, no limitation on the invention is intended by way of the foregoing description and accompanying drawings, except as set forth in the appended claims.
Infusion pumps of the general type described above have provided significant advantages and benefits with respect to accurate delivery of medication over an extended time period. The infusion pump is often designed to be extremely compact and may thus be adapted to be carried by the patient, for example, by means of a belt clip or the like. As a result, important medication can be administered with precision and in an automated manner, without significant restriction on the patients -mobility or life-style.
In the past, medication infusion pumps have included alarm systems designed to detect and indicate pump malfunction and/or nondelivery of the medication to the patient as a result of an occluded delivery line. Such alarm systems have typically used a high pressure limit switch for activating an alarm when the force applied to the syringe piston plunger reaches a predetermined upper limit indicative of an occluded medication delivery line.
In U.S. Patent 4,562,751, the high pressure switch is positioned at one end of a rotatable lead screw, wherein the mechanical reaction force or backlash between the syringe plunger and the pressure switch is proportional to the pressure applied to the medication as a result of attempted advancement of the syringe plunger. In actual practice, however, such high pressure limit switches have not provided the desired early warning of an occlusion, but instead have required multiple consecutive nondelivered doses before the pressure will rise to a level sufficient to activate the high pressure WO 96!27398 PCTIUS96102199 f ' . ~,'~* _3_ 1f switch. For many patients, it may take several hours for the occurrence of several consecutive doses, whereby an occlusion may go undetected for an undesirably long period of time. This problem is especially significant when the patient is a child, and wherein each dose comprises a relatively small volume of the medication.
There exists, therefore, a significant need for further improvements in medication infusion pumps particularly with respect to improved and rapid response occlusion detection for providing an early warning of an occlusion or other pump drive system failure. The present invention fulfills this need and provides further related advantages.
&UMMARY OF THE INVENTION
In accordance with the invention, a medication infusion pump is provided with an improved occlusion detector for monitoring medication delivery to a patient, and to provide an early alarm in the event of medication nondelivery. The occlusion detector comprises a force sensor and a related control circuit for reading and comparing the pressure applied to the medication at specific points in time relative to pump operation to administer the medication, and for activating an appropriate alarm in the event that the monitored pressure readings indicate an occlusion of the medication delivery lin e.
In the preferred form, the medication infusion pump comprises a compact pump housing for receiving and supporting a syringe filled with a prescribed medication such as insulin for administration to a patient through infusion tubing and an associated catheter or the like. A small stepping drive motor within the pump housing is programmably operated at intervals to rotate a lead h ..:~.
". .~s:~~ .
., ~. , . . .. e'.
screw, resulting in precision translation of a lead screw nut coupled to the piston plunger of the medication-containing syringe. The piston plunger is thus advanced incrementally to deliver prescribed ' medication doses from the syringe and through the infusion tubing to the patient. ' The force sensor of the occlusion detector is mounted at one end of the lead screw in a position for monitoring the drive force applied to the syringe piston plunger. That is, said drive force is coupled by mechanical reaction or backlash through the lead screw for detection and monitoring by the force sensor. The force detected by the sensor is directly proportional to the pressure applied to the medication within the syringe.
The control circuit causes the force sensor to read the pressure substantially at the time of administering a medication dose to the patient, and again at a later time preceding the next dose. The control circuit compares these two pressure readings, to determine whether the infusion tubing and/or catheter are occluded. Specifically, if the difference between the two pressure readings is less than a predetermined value, an occlusion is indicated and an alarm is activated. Conversely, if the compared difference is greater than said predetermined value, then the pressure applied to the medication within the syringe has dropped to reflect actual and proper medication delivery to the patient.
Other features and advantages of the present invention will become more apparent from the following detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, the principles of the invention.
R'O 96/27398 ~~gg6102199 _5_ :., .;~:~,~;~094 BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings illustrate the invention. In such drawings:
FIGURE 1 is a front perspective view illustrating a medication infusion pump for controlled delivery of medication to a patient, and further adapted to include the rapid response occlusion detector embodying the novel features of the invention;
FIGURE 2 is an enlarged rear elevation view of the infusion pump of FIG. 1, with portions broken away to illustrate pump operating components;
FIGURE 3 is a schematic circuit diagram illustrating the occlusion detector; and FIGURE 4 is a schematic circuit diagram depicting an alternative preferred form of the invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
As shown in the exemplary drawings, a medication infusion pump referred to generally in FIGURE 1 by the reference numeral 10 is provided for controlled administration of medication to a patient. In accordance with the invention, the infusion pump 10 includes a rapid response occlusion detector for monitoring and verifying proper delivery of the medication to the patient.
The infusion pump 10 has an overall construction and operation which is generally known ' in the art. More specifically, with respect to FIGS.
1 and 2, the infusion pump 10 comprises a relatively ' compact pump housing 12 defining an elongated chamber 14 (FIG. 2) for receiving and supporting a syringe 16 charged with a selected medication, such as insulin, to be administered to a patient. - The medication R'O 96127398 ~~ , PCTIUS96/02199 a _6_ -, containing syringe 16 includes a syringe barrel 18 joined at the front to a luer neck 20 of reduced diametric size to seat snugly within an outlet port 22 formed in the pump housing 12. A luer fitting 24 is carried on the neck 20 and cooperates with the barrel 18 to fix the syringe in a seated position within the syringe chamber 14. A syringe piston or plunger 26 extends from the aft end of the barrel 18 and may be advanced into the barrel to deliver the medication therefrom. In this regard, the medication is normally dispensed to the patient through a catheter tube 28 or the like adapted for appropriate connection to the luer fitting 24.
The infusion pump 10 includes a compact stepping drive motor 30 (FIG. 2) which is mechanically connected to the syringe plunger 26 for purposes of advancing the plunger in a precision controlled manner to dispense the medication. In this regard, the drive motor 3o is normally powered by a battery power supply 32 or the like, in response to operation of a programmable controller 34. As known in the art, the programmable controller 34 can be set by the attending physician, appropriate medical personnel, or the user by an array of buttons 36 on the face or front of the pump housing 12, with a corresponding display panel 38 providing appropriate information regarding set status and/or pump operation. The controller 34 operates the drive motor 30 in a stepwise manner, typically on an intermittent basis, to administer discrete precision doses of the medication to the patient at programmed times. ' The mechanical connection between the stepping drive motor 30 and the syringe plunger 26 includes a lead screw assembly 40. More specifically, the drive motor 30 has a rotary output for rotatably driving an elongated lead screw 42 _7_ mounted within the pump housing 12. A lead screw nut 44 is carried on the lead screw 42 and includes an appropriate latch arm 46 for engaging a drive flange 48 on the end of the piston plunger 26. Appropriate rotation of the lead screw 42 in response to operation of the stepping motor 30, causes the lead screw nut 44 and associated latch arm 46 to be translated in a precision manner to correspondingly advance the piston plunger 26 and thereby deliver the medication from the syringe barrel 18 and through the catheter tube 28 to the patient. Further details regarding the construction and operation of a medication infusion pump of this general type can be found in U.S. Patent Nos. 4,562,571; 4,678,408: and 4,685,903, The occlusion detector of the present invention is designed to provide early warning of system malfunction, particularly nondelivery of a medication dose to the patient as a result of an occluded medication flow path. In this regard, in general terms, translation of the lead screw nut 44 and the latch arm 46 to deliver medication from the syringe 16, will be accompanied by a rise in pressure applied to the medication within the syringe barrel 18. During normal operation with proper medication delivery to the patient, that pressure rise will subside within a relatively short period of time, reflecting medication flow out of the syringe barrel 1B and through the catheter tube 28 to the patient.
Nowever, if the flow path is obstructed, the pressure rise will not subside to any substantial degree.
Consecutive attempts to administer medication to the patient will result in a stepwise increase in the pressure applied to the medication within the syringe barrel.
The occlusion detector of the present 'invention monitors the pressure applied to the medication at spaced-apart points in time, to determine whether an occluded flow line condition exists. If the pressure reading comparison is less than a predetermined value, indicative of little or no subsiding in medication pressure following a dispense event, then an occlusion condition is promptly detected so that an appropriate alarm 50 (FIGS. 3 and 4) such as an audible alarm can be activated. Conversely, if the monitored pressure difference exceeds the predetermined value, reflective of proper subsidence in pressure level over a period of time, then normal pump medication delivery is indicated.
The occlusion detector includes a force sensor 52 such as a variable resistor force sensor of the type marketed by Interlink Electronics of Camarillo, California, under the product designation FSR~: As shown best in FIG. 2, the force sensor 52 is mounted on the pump housing 12 at one end of the lead screw 42. The force sensor 52 is positioned to monitor an axial reaction or backlash force applied to the lead screw 42 via the piston plunger 26 and the associated lead screw nut 44, when the lead screw 42 is rotated upon attempted delivery of the medication to the patient. Accordingly, the force sensor 52 detects a force which is directly proportional to the pressure applied to the medication within the syringe barrel 18.
As shown in FIG. 3 in one preferred form, the force sensor 52 provides an input signal to a control circuit 54 which is coupled with the pump programmable controller 34. As shown, the control circuit 54 includes an interface amplifier 56 and an analog-to-digital converter 58 for conditioning the * Trademark R'O 96/27398 PCTIUS96102199 _9_ ;~~-8794 output signal of the force sensor 52 and for supplying that output signal to a microprocessor 60 for storage and subsequent processing functions.
The microprocessor 60 is operated by the controller 34 to read and store the force reading outputs from the force sensor 52 in a memory 62. These force readings are taken substantially at the time of medication administration to the patient, i.e., immediately after lead screw rotation to advance the position plunger 26, and at a later time shortly preceding the next dose. These readings are compared to provide an indication of proper medication delivery, or nondelivery, as described above.
More particularly, the pressure applied to the medication within the syringe barrel 18 is relatively high when the syringe plunger 26 is advanced during a delivery event. However, this pressure will subside relatively quickly if the medication delivery path is unobstructed, since the pressure will be relieved by delivery of the medication dose to the patient. Conversely, if the delivery path is occluded, the pressure applied to the medication will not subside to a substantial degree. Accordingly, by comparing the readings from the force sensor 52 during a delivery event and at a later time such as shortly before the next delivery event, accurate occlusion monitoring is obtained. If the compared readings exceed a predetermined level indicative of substantial subsiding of the pressure within the syringe barrel 18, then proper medication delivery is indicated. However, if the compared readings are the same or otherwise less than said predetermined level, then nondelivery attributable to ° an occluded flow path is indicated.
In the preferred form, to prevent false alarms, the controller 34 and microprocessor 60 can be set to require a minimum number of perhaps two to four consecutive detected occlusion events before activating the alarm 50. This number of nondelivered doses, however, can be sufficiently small in number to provide the desired early occlusion warning for juvenile patients.
In addition, the system can be programmed to provide other alarm functions, particularly such as detecting failure of the lead screw 42 to rotate in response to operation of the stepping motor 30. In this mode, the microprocessor 6~ reads force signals for the force sensor 52 immediately before and after stepping motor operation. If the monitored force signals are reflective of a pressure rise within the syringe barrel 18, in response to the desired advancement of the syringe plunger 26, then normal operation is indicated. However, if no pressure rise is detected by comparing these force readings, then the syringe plunger 26 has not been advanced as a result of some drive system failure, whereupon the alarm 50 can be activated.
A further safeguard is desirably included in the control circuit 54 to prevent false alarms during initial primary of the ,catheter tube 28. In this process, the controller 34 and microprocessor 60 are set to ignore pressure-indicative output signals from the force sensor 52 unless and until those signals exceed a predetermined low level threshold. That is, during normal operation with the tubing 2B primed, pressures below the low level threshold are not encountered.
FIGURE 4 illustrates one alternative form of the control circuit, wherein components corresponding functionally to those shown and described in FIG. 3 are identified by common primed reference numerals.
As shown, the force sensor 52' is coupled by an interface amplifier 56' to a switch logic circuit 60'. The programmable controller 34 operates the WO 96/27398 PCTlUS96102199 ::.
~~'~ 218 ~0 9 4 circuit 60' to 'read and store force reading's at a time substantially corresponding with medication delivery to the patient, and at a later time shortly preceding the next dosage, by appropriate opening and closure, respectively, of a pair of switches 65 and 66 for coupling these readings to the minus and plus inputs of a comparator 68. The force readings are compared by the comparator 68, and an appropriate alarm 50 is activated when the difference between the compared readings is less than a predetermined value indicative of an occlusion, as described previously with respect to FIG. 3. A variable resistor offset 70 is inputted to the comparator 68 to set the difference threshold required to activate the alarm.
In addition, a minimum force comparator circuit 72 is desirably provided to disable the comparator 68 when the detected force levels are sufficiently low to indicate a pump priming procedure.
The invention thus provides accurate and rapid response occlusion detection by monitoring pressure differentials at predetermined points in time relative to medication delivery events. With this approach, an occlusion condition or other drive system failure can be detected promptly, without requiring any significant number of consecutive delivery failures and a corresponding prolonged period of medication nondelivery to a patient. Rapid occlusion detection can be particularly important to those patients who receive medication doses of very small volumes, particularly patients such as children.
A variety of further modifications and improvements to the invention will be apparent to those skilled in the art. Accordingly, no limitation on the invention is intended by way of the foregoing description and accompanying drawings, except as set forth in the appended claims.
Claims (12)
1. A failure mode detector for use with a medication infusion pump having a syringe defining a chamber with medication therein, infusion tubing for connecting the medication chamber to a patient, a piston plunger for advancement into the medication chamber to administer a dose of the medication to the patient, and drive means for controllably advancing the piston plunger into the medication chamber to administer a succession of discrete doses of the medication to the patient, said failure mode detector comprising:
force sensor means for monitoring and for providing output signals representative of a pressure applied to the medication within the medication chamber;
control circuit means connected to said force sensor means for receiving said output signals, said control circuit means including comparator means for comparing a difference between first and second output signals taken at different selected points in time wherein a failure mode is indicated when said difference is outside a predetermined range; and alarm means activated by said control circuit means when said difference indicates the failure mode.
force sensor means for monitoring and for providing output signals representative of a pressure applied to the medication within the medication chamber;
control circuit means connected to said force sensor means for receiving said output signals, said control circuit means including comparator means for comparing a difference between first and second output signals taken at different selected points in time wherein a failure mode is indicated when said difference is outside a predetermined range; and alarm means activated by said control circuit means when said difference indicates the failure mode.
2. The detector of claim 1 wherein said comparator means compares the difference between said first output signal taken substantially at a point in time corresponding with advancement of the piston plunger to administer the dose of the medication and said second output signal taken at a later point in time substantially after said plunger advancement but preceding a next dose, said alarm means being activated when the difference between said first and second output signals is less than a predetermined value.
3. The detector of claim 1 wherein the drive means comprises a lead screw assembly including a lead screw rotatably supported within a pump housing, a lead screw nut threadably carried on said lead screw and including means connected to the syringe plunger, and a stepping motor for rotatably driving the lead screw, said force sensor means comprising a variable resistor force detector mounted between one end of said lead screw and the pump housing to detect a reaction force applied to the lead screw in proportion to the pressure applied to the medication within the medication chamber.
4. The detector of claim 2 wherein said control circuit means includes means for preventing activation of said alarm means until the difference between said first and second output signals is less than said predetermined value for a predetermined consecutive number of doses.
5. The detector of claim 1 wherein said control circuit means includes means for preventing activation of said alarm means unless the first output signal exceeds a predetermined low level limit.
6. The detector of claim 2 wherein said control circuit means further includes means for comparing the difference between a third output signal substantially at a point in time immediately preceding advancement of the syringe plunger to administer medication and a fourth output signal at a later point in time corresponding with advancement of the syringe plunger to administer medication, said alarm means being activated by said control circuit means when the difference between said third and fourth output signals is less than the predetermined value.
7. A method of detecting a failure mode in a medication infusion pump having a syringe defining a chamber with medication therein, infusion tubing for connecting the medication chamber to a patient, a piston plunger for advancement into the medication chamber to administer a dose of the medication to the patient, and drive means for controllably advancing the piston plunger into the medication chamber to administer a succession of discrete doses of the medication to the patient, said method comprising the steps of:
monitoring and providing output signals representative of a pressure applied to the medication within the medication chamber;
comparing a difference between first and second output signals taken at different selected points in time wherein the failure mode is indicated when said difference is outside a predetermined range; and activating an alarm when said difference indicates the failure mode.
monitoring and providing output signals representative of a pressure applied to the medication within the medication chamber;
comparing a difference between first and second output signals taken at different selected points in time wherein the failure mode is indicated when said difference is outside a predetermined range; and activating an alarm when said difference indicates the failure mode.
8. The method of claim 7 wherein said comparing step comprises comparing the difference between said first output signal corresponding substantially at a point in time with advancement of the piston plunger to administer the dose of the medication and said second output signal at a later point in time substantially after said plunger advancement but preceding a next dose, and said alarm activating step comprising activating the alarm when the difference between said first and second output signals is less than a predetermined value.
9. The method of claim 7 wherein the drive means comprises a lead screw assembly including a lead screw rotatably supported within a pump housing, a lead screw nut threadably carried on said lead screw and including means connected to the syringe plunger, and a stepping motor for rotatably driving the lead screw, said pressure monitoring step comprising detecting a reaction force applied to the lead screw in proportion to the pressure applied to the medication within the medication chamber.
10. The method of claim 8 further including the step of disabling the alarm until the difference between said first and second output signals is less than said predetermined value for a predetermined consecutive number of doses.
11. The method of claim 7 further including the step of disabling the alarm unless the first output signal exceeds a predetermined low level limit.
12. The method of claim 8 further including the steps of comparing the difference between a third output signal substantially at a point in time immediately preceding advancement of the syringe plunger to administer medication and a fourth output signal at a later point in time corresponding with advancement of the syringe plunger to administer medication, and activating the alarm when the difference between said third and fourth output signals is less than the predetermined value.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/397,797 | 1995-03-03 | ||
US08/397,797 US5647853A (en) | 1995-03-03 | 1995-03-03 | Rapid response occlusion detector for a medication infusion pump |
PCT/US1996/002199 WO1996027398A1 (en) | 1995-03-03 | 1996-02-20 | Rapid response occlusion detector for a medication infusion pump |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2187094A1 CA2187094A1 (en) | 1996-09-12 |
CA2187094C true CA2187094C (en) | 2006-01-31 |
Family
ID=23572659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002187094A Expired - Fee Related CA2187094C (en) | 1995-03-03 | 1996-02-20 | Rapid response occlusion detector for a medication infusion pump |
Country Status (6)
Country | Link |
---|---|
US (1) | US5647853A (en) |
EP (1) | EP0758253B1 (en) |
JP (1) | JP4188414B2 (en) |
CA (1) | CA2187094C (en) |
DE (1) | DE69625294T2 (en) |
WO (1) | WO1996027398A1 (en) |
Families Citing this family (283)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE510420C2 (en) * | 1994-11-14 | 1999-05-25 | Cma Microdialysis Ab | Infusion and microdialysis pump |
JP3874484B2 (en) * | 1997-03-05 | 2007-01-31 | スーガン株式会社 | Medical injector head |
US5808203A (en) * | 1997-05-12 | 1998-09-15 | Medrad, Inc. | Fluid pressure measurement devices |
DE19723648C1 (en) | 1997-06-05 | 1998-08-27 | Disetronic Licensing Ag | Controlled infusion equipment with leak and reverse flow prevention used e.g. in insulin therapy |
US5954643A (en) * | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
CH692543A5 (en) | 1997-09-25 | 2002-07-31 | Disetronic Licensing Ag | Dispenser with auto switch. |
US6056718A (en) | 1998-03-04 | 2000-05-02 | Minimed Inc. | Medication infusion set |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US5993423A (en) * | 1998-08-18 | 1999-11-30 | Choi; Soo Bong | Portable automatic syringe device and injection needle unit thereof |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
DE19840992A1 (en) | 1998-09-08 | 2000-03-09 | Disetronic Licensing Ag | Pressure monitoring of a product fluid to be administered in doses during an infusion or injection |
DE19840965A1 (en) * | 1998-09-08 | 2000-03-09 | Disetronic Licensing Ag | Device for self-administration of a product fluid |
US7621893B2 (en) * | 1998-10-29 | 2009-11-24 | Medtronic Minimed, Inc. | Methods and apparatuses for detecting occlusions in an ambulatory infusion pump |
US6248093B1 (en) * | 1998-10-29 | 2001-06-19 | Minimed Inc. | Compact pump drive system |
US20020173748A1 (en) | 1998-10-29 | 2002-11-21 | Mcconnell Susan | Reservoir connector |
US7193521B2 (en) * | 1998-10-29 | 2007-03-20 | Medtronic Minimed, Inc. | Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump |
US6800071B1 (en) * | 1998-10-29 | 2004-10-05 | Medtronic Minimed, Inc. | Fluid reservoir piston |
US6817990B2 (en) | 1998-10-29 | 2004-11-16 | Medtronic Minimed, Inc. | Fluid reservoir piston |
CA2533850C (en) | 1998-10-29 | 2009-09-01 | Medtronic Minimed, Inc. | Reservoir connector |
US7766873B2 (en) | 1998-10-29 | 2010-08-03 | Medtronic Minimed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
US6164921A (en) | 1998-11-09 | 2000-12-26 | Moubayed; Ahmad Maher | Curvilinear peristaltic pump having insertable tubing assembly |
US6645177B1 (en) * | 1999-02-09 | 2003-11-11 | Alaris Medical Systems, Inc. | Directly engaged syringe driver system |
US6423035B1 (en) | 1999-06-18 | 2002-07-23 | Animas Corporation | Infusion pump with a sealed drive mechanism and improved method of occlusion detection |
GB9915525D0 (en) | 1999-07-03 | 1999-09-01 | Smiths Industries Plc | Syringe pumps |
DE19947826B4 (en) * | 1999-10-05 | 2006-06-08 | Disetronic Licensing Ag | Device for the metered administration of an injectable product |
US7063684B2 (en) * | 1999-10-28 | 2006-06-20 | Medtronic Minimed, Inc. | Drive system seal |
FR2806310B1 (en) * | 2000-03-16 | 2002-05-24 | Fresenius Vial | METHOD FOR ANALYZING THE PRESSURE VARIATION IN A PERFUSION DEVICE COMPRISING A PLURALITY OF INFUSION MODULES |
US6485465B2 (en) * | 2000-03-29 | 2002-11-26 | Medtronic Minimed, Inc. | Methods, apparatuses, and uses for infusion pump fluid pressure and force detection |
US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
US6652493B1 (en) | 2000-07-05 | 2003-11-25 | Animas Corporation | Infusion pump syringe |
GB0020060D0 (en) * | 2000-08-16 | 2000-10-04 | Smiths Industries Plc | Syringe pumps |
ES2287156T3 (en) * | 2000-09-08 | 2007-12-16 | Insulet Corporation | DEVICES AND SYSTEMS FOR THE INFUSION OF A PATIENT. |
US6669669B2 (en) * | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
US6609431B1 (en) | 2000-09-29 | 2003-08-26 | Xellogy, Inc. | Flow measuring device based on predetermine class of liquid |
US7500959B2 (en) * | 2000-10-05 | 2009-03-10 | Novo Nordisk A/S | Medication delivery system with improved dose accuracy |
US6572604B1 (en) | 2000-11-07 | 2003-06-03 | Baxter International Inc. | Occlusion detection method and system for ambulatory drug infusion pump |
US6699218B2 (en) | 2000-11-09 | 2004-03-02 | Insulet Corporation | Transcutaneous delivery means |
DE60115707T2 (en) | 2000-12-21 | 2006-08-10 | Insulet Corp., Beverly | REMOTE CONTROL MEDICAL DEVICE |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
CN1556716A (en) | 2001-02-22 | 2004-12-22 | ���Ͽع�����˾ | Modular infusion device and method |
WO2002078512A2 (en) | 2001-04-02 | 2002-10-10 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6856251B1 (en) | 2001-04-26 | 2005-02-15 | Xsilogy, Inc. | Systems and methods for sensing pressure |
US6992590B1 (en) | 2001-04-27 | 2006-01-31 | Xsilogy, Inc. | Systems and methods for sensing a fluid supply status |
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
MXPA03010576A (en) | 2001-05-18 | 2004-05-27 | Deka Products Lp | Infusion set for a fluid pump. |
JP2003070909A (en) * | 2001-08-30 | 2003-03-11 | Japan Servo Co Ltd | Transfusion device |
US6974438B2 (en) | 2001-10-22 | 2005-12-13 | L.G. Med Ltd. | Method and device for detecting malfunction in a gravity fed intravenous delivery system |
US20040078028A1 (en) * | 2001-11-09 | 2004-04-22 | Flaherty J. Christopher | Plunger assembly for patient infusion device |
US6736796B2 (en) | 2001-11-26 | 2004-05-18 | Nili-Med Ltd. | Fluid drug delivery device |
US7291126B2 (en) * | 2001-11-26 | 2007-11-06 | Nilimedix Ltd. | Drug delivery device and method |
US7311693B2 (en) * | 2001-11-26 | 2007-12-25 | Nilimedix Ltd. | Drug delivery device and method |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US6692457B2 (en) * | 2002-03-01 | 2004-02-17 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6830558B2 (en) | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6656158B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US6656159B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US6960192B1 (en) | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
US20040153032A1 (en) * | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
US20050238507A1 (en) * | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
JP3854190B2 (en) * | 2002-04-26 | 2006-12-06 | 株式会社ジェイテクト | Motor control device |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
US7018361B2 (en) | 2002-06-14 | 2006-03-28 | Baxter International Inc. | Infusion pump |
US7018360B2 (en) * | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
US20040068230A1 (en) * | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US6804119B2 (en) | 2002-07-31 | 2004-10-12 | Hewlett-Packard Development Company, L.P. | Method and edge connector providing electrostatic discharge arrest features and digital camera employing same |
US7527608B2 (en) * | 2002-08-12 | 2009-05-05 | Lma North America, Inc. | Medication infusion and aspiration system and method |
US6893414B2 (en) * | 2002-08-12 | 2005-05-17 | Breg, Inc. | Integrated infusion and aspiration system and method |
US7128727B2 (en) * | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
US7144384B2 (en) * | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US20040133166A1 (en) * | 2002-11-22 | 2004-07-08 | Minimed Inc. | Methods, apparatuses, and uses for infusion pump fluid pressure and force detection |
US20040116866A1 (en) * | 2002-12-17 | 2004-06-17 | William Gorman | Skin attachment apparatus and method for patient infusion device |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US20050182366A1 (en) * | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
ES2737835T3 (en) | 2003-04-23 | 2020-01-16 | Valeritas Inc | Hydraulically driven pump for long-term medication administration |
JP4509100B2 (en) * | 2003-05-08 | 2010-07-21 | ノボ・ノルデイスク・エー/エス | Infusion device attachable to skin with removable needle insertion actuation |
ATE392223T1 (en) * | 2003-05-08 | 2008-05-15 | Novo Nordisk As | INTERNAL NEEDLE INTRODUCER |
EP1475113A1 (en) * | 2003-05-08 | 2004-11-10 | Novo Nordisk A/S | External needle inserter |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
EP1502613A1 (en) * | 2003-08-01 | 2005-02-02 | Novo Nordisk A/S | Needle device with retraction means |
JP2005074065A (en) * | 2003-09-02 | 2005-03-24 | Nemoto Kyorindo:Kk | Medicinal solution injection apparatus |
US20050065760A1 (en) * | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
US20050070847A1 (en) * | 2003-09-29 | 2005-03-31 | Van Erp Wilhelmus Petrus Martinus Maria | Rapid-exchange balloon catheter with hypotube shaft |
KR20060099520A (en) * | 2003-10-21 | 2006-09-19 | 노보 노르디스크 에이/에스 | Medical skin mountable device |
US8182461B2 (en) * | 2003-11-04 | 2012-05-22 | Smiths Medical Asd, Inc. | Syringe pump rapid occlusion detection system |
WO2005054999A2 (en) * | 2003-11-26 | 2005-06-16 | E-Z-Em, Inc. | Device, method, and computer program product for dispensing media as part of a medical procedure |
EP1699381A4 (en) * | 2003-12-29 | 2007-12-05 | Animas Corp | Methods and systems for detecting an occlusion |
KR20060130648A (en) * | 2004-01-12 | 2006-12-19 | 아이싸이언스 인터벤셔날 코포레이션 | Injector for viscous materials |
EP1718198A4 (en) | 2004-02-17 | 2008-06-04 | Therasense Inc | Method and system for providing data communication in continuous glucose monitoring and management system |
KR20060131945A (en) * | 2004-03-30 | 2006-12-20 | 노보 노르디스크 에이/에스 | Actuator system comprising detection means |
CN100586495C (en) * | 2004-03-30 | 2010-02-03 | 诺和诺德公司 | Actuator system comprising lever mechanism |
ITMO20040082A1 (en) * | 2004-04-13 | 2004-07-13 | Gambro Lundia Ab | CONNECTOR FOR A FLUID LINE OF AN EXTACORPOREO CIRCUIT |
ITMO20040085A1 (en) * | 2004-04-20 | 2004-07-20 | Gambro Lundia Ab | INFUSION DEVICE FOR MEDICAL FLUIDS. |
DE102004019053A1 (en) * | 2004-04-20 | 2005-11-24 | Disetronic Licensing Ag | Apparatus and method for occlusion detection in infusion pumps |
WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
US9463287B1 (en) | 2004-09-20 | 2016-10-11 | Bing Innovations, Llc | Controlling usage of replaceable tool ends |
US9168340B2 (en) | 2009-03-27 | 2015-10-27 | Bing Innovations, Llc | System and method for pain reduction during skin puncture and breakable tip therefor |
WO2010110823A1 (en) | 2009-03-27 | 2010-09-30 | Bing Innovations, Llc | Apparatus and method for reducing pain during skin puncturing procedures |
US20090012472A1 (en) * | 2004-09-22 | 2009-01-08 | Novo Nordisk A/S | Medical Device with Cannula Inserter |
CN101027095B (en) * | 2004-09-22 | 2010-09-29 | 诺和诺德公司 | Medical device with cannula inserter |
DE102004046875A1 (en) * | 2004-09-28 | 2006-04-13 | Robert Bosch Gmbh | Device for the metered filling of a liquid |
EP1824536B1 (en) * | 2004-12-06 | 2009-08-26 | Novo Nordisk A/S | Ventilated skin mountable device |
DE102004063650B4 (en) | 2004-12-31 | 2022-10-20 | Ypsomed Ag | Lifetime indicator for a product metering device |
JP2008528086A (en) | 2005-01-24 | 2008-07-31 | ノボ・ノルデイスク・エー/エス | Medical device with protected puncture device |
US20060178633A1 (en) * | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
WO2006120253A2 (en) * | 2005-05-13 | 2006-11-16 | Novo Nordisk A/S | Medical device adapted to detect disengagement of a transcutaneous device |
US20070000301A1 (en) * | 2005-06-21 | 2007-01-04 | Todd Kirk W | Reflux control in microsurgical system |
EP1759727A1 (en) * | 2005-09-02 | 2007-03-07 | F.Hoffmann-La Roche Ag | Infusion device having a control unit |
WO2007035563A2 (en) * | 2005-09-19 | 2007-03-29 | Lifescan, Inc. | Malfunction detection via pressure pulsation |
US20070066940A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Systems and Methods for Detecting a Partition Position in an Infusion Pump |
WO2007035567A2 (en) * | 2005-09-19 | 2007-03-29 | Lifescan, Inc. | Infusion pump with closed loop control and algorithm |
US7326183B2 (en) * | 2005-09-28 | 2008-02-05 | Alcon, Inc. | Intraocular pressure control |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
US11027058B2 (en) | 2006-02-09 | 2021-06-08 | Deka Products Limited Partnership | Infusion pump assembly |
EP2335754B1 (en) | 2006-02-09 | 2013-12-18 | DEKA Products Limited Partnership | Patch-sized fluid delivery systems |
US10010669B2 (en) | 2006-02-09 | 2018-07-03 | Deka Products Limited Partnership | Systems and methods for fluid delivery |
US11364335B2 (en) | 2006-02-09 | 2022-06-21 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US11497846B2 (en) | 2006-02-09 | 2022-11-15 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
US9173992B2 (en) | 2006-03-13 | 2015-11-03 | Novo Nordisk A/S | Secure pairing of electronic devices using dual means of communication |
JP2009532117A (en) | 2006-03-30 | 2009-09-10 | ヴァレリタス,エルエルシー | Multi-cartridge fluid dispensing device |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
EP2012852A1 (en) * | 2006-04-26 | 2009-01-14 | Novo Nordisk A/S | Skin-mountable device in packaging comprising coated seal member |
WO2007141210A1 (en) | 2006-06-06 | 2007-12-13 | Novo Nordisk A/S | Assembly comprising skin-mountable device and packaging therefore |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US8167832B2 (en) | 2006-12-09 | 2012-05-01 | The Alfred E. Mann Foundation For Scientific Research | Ambulatory infusion devices and methods including occlusion monitoring |
US7654127B2 (en) * | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US20100063448A1 (en) * | 2007-03-06 | 2010-03-11 | Novo Nordisk A/S | Pump assembly comprising actuator system |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9199022B2 (en) | 2008-09-12 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Modular reservoir assembly for a hemodialysis and hemofiltration system |
US8597505B2 (en) | 2007-09-13 | 2013-12-03 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine |
US8240636B2 (en) | 2009-01-12 | 2012-08-14 | Fresenius Medical Care Holdings, Inc. | Valve system |
US9308307B2 (en) | 2007-09-13 | 2016-04-12 | Fresenius Medical Care Holdings, Inc. | Manifold diaphragms |
US8105487B2 (en) | 2007-09-25 | 2012-01-31 | Fresenius Medical Care Holdings, Inc. | Manifolds for use in conducting dialysis |
US9358331B2 (en) | 2007-09-13 | 2016-06-07 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine with improved reservoir heating system |
US7934912B2 (en) | 2007-09-27 | 2011-05-03 | Curlin Medical Inc | Peristaltic pump assembly with cassette and mounting pin arrangement |
US8083503B2 (en) | 2007-09-27 | 2011-12-27 | Curlin Medical Inc. | Peristaltic pump assembly and regulator therefor |
US8062008B2 (en) | 2007-09-27 | 2011-11-22 | Curlin Medical Inc. | Peristaltic pump and removable cassette therefor |
US9656019B2 (en) | 2007-10-02 | 2017-05-23 | Medimop Medical Projects Ltd. | Apparatuses for securing components of a drug delivery system during transport and methods of using same |
US7967795B1 (en) | 2010-01-19 | 2011-06-28 | Lamodel Ltd. | Cartridge interface assembly with driving plunger |
US10420880B2 (en) | 2007-10-02 | 2019-09-24 | West Pharma. Services IL, Ltd. | Key for securing components of a drug delivery system during assembly and/or transport and methods of using same |
WO2009044401A2 (en) | 2007-10-02 | 2009-04-09 | Yossi Gross | External drug pump |
US9345836B2 (en) | 2007-10-02 | 2016-05-24 | Medimop Medical Projects Ltd. | Disengagement resistant telescoping assembly and unidirectional method of assembly for such |
US20090101673A1 (en) * | 2007-10-17 | 2009-04-23 | Alioto George S | Motorized extrusion tool |
CN101888859B (en) * | 2007-10-31 | 2014-09-17 | 诺沃-诺迪斯克有限公司 | Non-porous material as sterilization barrier |
CA3057806C (en) | 2007-11-29 | 2021-11-23 | Fresenius Medical Care Holdings, Inc. | System and method for conducting hemodialysis and hemofiltration |
US10188787B2 (en) | 2007-12-31 | 2019-01-29 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8900188B2 (en) | 2007-12-31 | 2014-12-02 | Deka Products Limited Partnership | Split ring resonator antenna adapted for use in wirelessly controlled medical device |
US9456955B2 (en) | 2007-12-31 | 2016-10-04 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
RU2510758C2 (en) | 2007-12-31 | 2014-04-10 | Дека Продактс Лимитед Партнершип | Infusion pump assembly |
US10080704B2 (en) | 2007-12-31 | 2018-09-25 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8414563B2 (en) | 2007-12-31 | 2013-04-09 | Deka Products Limited Partnership | Pump assembly with switch |
US8881774B2 (en) | 2007-12-31 | 2014-11-11 | Deka Research & Development Corp. | Apparatus, system and method for fluid delivery |
US7867192B2 (en) | 2008-02-29 | 2011-01-11 | The Alfred E. Mann Foundation For Scientific Research | Ambulatory infusion devices and methods with blockage detection |
US20090247955A1 (en) * | 2008-03-27 | 2009-10-01 | Iscience Interventional Corporation | Microliter injector |
CA2724641C (en) | 2008-05-20 | 2020-03-24 | Avant Medical Corp. | Autoinjector system |
US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
WO2009140782A1 (en) * | 2008-05-23 | 2009-11-26 | Tecpharma Licensing Ag | Pressure monitor in a modular administering device |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US9393369B2 (en) | 2008-09-15 | 2016-07-19 | Medimop Medical Projects Ltd. | Stabilized pen injector |
CA2739786C (en) | 2008-10-07 | 2018-01-02 | Fresenius Medical Care Holdings, Inc. | Priming system and method for dialysis systems |
US8262616B2 (en) | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US8066672B2 (en) | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8708376B2 (en) | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
US8016789B2 (en) | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
US8105269B2 (en) | 2008-10-24 | 2012-01-31 | Baxter International Inc. | In situ tubing measurements for infusion pumps |
CN102639201B (en) | 2008-10-30 | 2015-07-08 | 弗雷塞尼斯医疗保健控股公司 | Modular, portable dialysis system |
CN102197304B (en) | 2008-11-04 | 2013-08-28 | 松下电器产业株式会社 | Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program |
NL2002343C2 (en) * | 2008-12-18 | 2010-06-21 | Apad Octrooi B V | DEVICE FOR LOCALIZING A STRUCTURE IN THE INTERIOR OF A BODY. |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8137083B2 (en) | 2009-03-11 | 2012-03-20 | Baxter International Inc. | Infusion pump actuators, system and method for controlling medical fluid flowrate |
DK2241344T3 (en) | 2009-04-16 | 2014-03-03 | Hoffmann La Roche | Portable infusion with feel-testing device |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
WO2011008966A2 (en) | 2009-07-15 | 2011-01-20 | Deka Products Limited Partnership | Apparatus, systems and methods for an infusion pump assembly |
EP2724739B1 (en) | 2009-07-30 | 2015-07-01 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US10071198B2 (en) | 2012-11-02 | 2018-09-11 | West Pharma. Servicees IL, Ltd. | Adhesive structure for medical device |
US8157769B2 (en) | 2009-09-15 | 2012-04-17 | Medimop Medical Projects Ltd. | Cartridge insertion assembly for drug delivery system |
US10071196B2 (en) | 2012-05-15 | 2018-09-11 | West Pharma. Services IL, Ltd. | Method for selectively powering a battery-operated drug-delivery device and device therefor |
EP2482720A4 (en) | 2009-09-29 | 2014-04-23 | Abbott Diabetes Care Inc | Method and apparatus for providing notification function in analyte monitoring systems |
US8382447B2 (en) | 2009-12-31 | 2013-02-26 | Baxter International, Inc. | Shuttle pump with controlled geometry |
US8348898B2 (en) | 2010-01-19 | 2013-01-08 | Medimop Medical Projects Ltd. | Automatic needle for drug pump |
EP2525848B1 (en) | 2010-01-22 | 2016-08-03 | DEKA Products Limited Partnership | System for shape-memory alloy wire control |
EP2547382B1 (en) * | 2010-03-16 | 2021-08-04 | Sanofi-Aventis Deutschland GmbH | Controlling a motor of an injection device |
WO2011126895A2 (en) * | 2010-03-30 | 2011-10-13 | Deka Products Limited Partnership | Infusion pump methods, systems and apparatus |
EP2569031B1 (en) | 2010-05-10 | 2017-10-11 | Medimop Medical Projects Ltd. | Low volume accurate injector |
US8567235B2 (en) | 2010-06-29 | 2013-10-29 | Baxter International Inc. | Tube measurement technique using linear actuator and pressure sensor |
WO2012059209A1 (en) | 2010-11-01 | 2012-05-10 | Roche Diagnostics Gmbh | Fluid dispensing device with a flow detector |
USD702834S1 (en) | 2011-03-22 | 2014-04-15 | Medimop Medical Projects Ltd. | Cartridge for use in injection device |
LT2699293T (en) | 2011-04-20 | 2019-04-25 | Amgen Inc. | Autoinjector apparatus |
EP2729200B1 (en) * | 2011-07-06 | 2016-10-19 | F.Hoffmann-La Roche Ag | Automatic injection device comprising two occlusion sensors |
EP2775918B1 (en) | 2011-11-07 | 2020-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
EP2809375B1 (en) | 2012-01-31 | 2021-08-11 | Medimop Medical Projects Ltd. | Time dependent drug delivery apparatus |
WO2013134519A2 (en) | 2012-03-07 | 2013-09-12 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US9463280B2 (en) | 2012-03-26 | 2016-10-11 | Medimop Medical Projects Ltd. | Motion activated septum puncturing drug delivery device |
US10668213B2 (en) | 2012-03-26 | 2020-06-02 | West Pharma. Services IL, Ltd. | Motion activated mechanisms for a drug delivery device |
US9072827B2 (en) | 2012-03-26 | 2015-07-07 | Medimop Medical Projects Ltd. | Fail safe point protector for needle safety flap |
EP3549524B1 (en) | 2012-03-30 | 2023-01-25 | Insulet Corporation | Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
CN104349712A (en) * | 2012-05-25 | 2015-02-11 | 史密斯医疗Asd公司 | Occlusion detection |
KR20150048816A (en) | 2012-08-31 | 2015-05-07 | 백스터 코포레이션 잉글우드 | Medication requisition fulfillment system and method |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9375079B2 (en) | 2012-10-26 | 2016-06-28 | Baxter Corporation Englewood | Work station for medical dose preparation system |
KR101974258B1 (en) | 2012-10-26 | 2019-04-30 | 백스터 코포레이션 잉글우드 | Improved image acquisition for medical dose preparation system |
US9201036B2 (en) | 2012-12-21 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Method and system of monitoring electrolyte levels and composition using capacitance or induction |
US9157786B2 (en) | 2012-12-24 | 2015-10-13 | Fresenius Medical Care Holdings, Inc. | Load suspension and weighing system for a dialysis machine reservoir |
ES2749187T3 (en) | 2012-12-31 | 2020-03-19 | Gambro Lundia Ab | Detection of occlusions in fluid administration |
US9421323B2 (en) | 2013-01-03 | 2016-08-23 | Medimop Medical Projects Ltd. | Door and doorstop for portable one use drug delivery apparatus |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US9011164B2 (en) | 2013-04-30 | 2015-04-21 | Medimop Medical Projects Ltd. | Clip contact for easy installation of printed circuit board PCB |
US9889256B2 (en) | 2013-05-03 | 2018-02-13 | Medimop Medical Projects Ltd. | Sensing a status of an infuser based on sensing motor control and power input |
WO2015003145A1 (en) | 2013-07-03 | 2015-01-08 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
WO2015036359A1 (en) * | 2013-09-10 | 2015-03-19 | Sanofi-Aventis Deutschland Gmbh | Actuation step failure handling |
US9849221B2 (en) * | 2013-10-04 | 2017-12-26 | Flex Fluidics, Llc | Inline pump with rear attachable syringe |
US9354640B2 (en) * | 2013-11-11 | 2016-05-31 | Fresenius Medical Care Holdings, Inc. | Smart actuator for valve |
US20150182697A1 (en) | 2013-12-31 | 2015-07-02 | Abbvie Inc. | Pump, motor and assembly for beneficial agent delivery |
US10441717B2 (en) | 2014-04-15 | 2019-10-15 | Insulet Corporation | Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication |
JP2017525032A (en) | 2014-06-30 | 2017-08-31 | バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood | Managed medical information exchange |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
WO2016090091A1 (en) | 2014-12-05 | 2016-06-09 | Baxter Corporation Englewood | Dose preparation data analytics |
SG11201707114XA (en) | 2015-03-03 | 2017-09-28 | Baxter Corp Englewood | Pharmacy workflow management with integrated alerts |
US9795534B2 (en) | 2015-03-04 | 2017-10-24 | Medimop Medical Projects Ltd. | Compliant coupling assembly for cartridge coupling of a drug delivery device |
US10251813B2 (en) | 2015-03-04 | 2019-04-09 | West Pharma. Services IL, Ltd. | Flexibly mounted cartridge alignment collar for drug delivery device |
US10293120B2 (en) | 2015-04-10 | 2019-05-21 | West Pharma. Services IL, Ltd. | Redundant injection device status indication |
US9744297B2 (en) | 2015-04-10 | 2017-08-29 | Medimop Medical Projects Ltd. | Needle cannula position as an input to operational control of an injection device |
US10589016B2 (en) | 2015-04-15 | 2020-03-17 | Gambro Lundia Ab | Treatment system with infusion apparatus pressure priming |
US10695508B2 (en) | 2015-05-01 | 2020-06-30 | Bing Innovations, Llc | Reducing pain of skin piercing using vibration |
US10149943B2 (en) | 2015-05-29 | 2018-12-11 | West Pharma. Services IL, Ltd. | Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly |
AU2016271561A1 (en) | 2015-06-04 | 2017-12-07 | Smiths Medical Asd, Inc. | Procedure-based programming for infusion pumps |
WO2016196934A1 (en) | 2015-06-04 | 2016-12-08 | Medimop Medical Projects Ltd. | Cartridge insertion for drug delivery device |
US10729848B2 (en) | 2015-06-17 | 2020-08-04 | Smiths Medical Asd, Inc. | Force sensing devices, systems and methods for syringe pumps |
WO2016207206A1 (en) | 2015-06-25 | 2016-12-29 | Gambro Lundia Ab | Medical device system and method having a distributed database |
US9987432B2 (en) | 2015-09-22 | 2018-06-05 | West Pharma. Services IL, Ltd. | Rotation resistant friction adapter for plunger driver of drug delivery device |
US10576207B2 (en) | 2015-10-09 | 2020-03-03 | West Pharma. Services IL, Ltd. | Angled syringe patch injector |
US10086145B2 (en) | 2015-09-22 | 2018-10-02 | West Pharma Services Il, Ltd. | Rotation resistant friction adapter for plunger driver of drug delivery device |
CN113648488B (en) | 2015-10-09 | 2024-03-29 | 西医药服务以色列分公司 | Curved fluid path attachment to prefilled fluid reservoir |
EP3380061A4 (en) | 2015-11-24 | 2019-07-24 | Insulet Corporation | Wearable automated medication delivery system |
WO2017091584A1 (en) | 2015-11-25 | 2017-06-01 | Insulet Corporation | Wearable medication delivery device |
CN108778371B (en) | 2016-01-20 | 2020-08-07 | 梅戴林治疗公司 | Ambulatory infusion device and related methods |
WO2017127215A1 (en) | 2016-01-21 | 2017-07-27 | Medimop Medical Projects Ltd. | Needle insertion and retraction mechanism |
CN111544704B (en) | 2016-01-21 | 2022-06-03 | 西医药服务以色列有限公司 | Force containment in autoinjectors |
CN113041432B (en) | 2016-01-21 | 2023-04-07 | 西医药服务以色列有限公司 | Medicament delivery device comprising a visual indicator |
US11389597B2 (en) | 2016-03-16 | 2022-07-19 | West Pharma. Services IL, Ltd. | Staged telescopic screw assembly having different visual indicators |
US10376647B2 (en) | 2016-03-18 | 2019-08-13 | West Pharma. Services IL, Ltd. | Anti-rotation mechanism for telescopic screw assembly |
EP3463526A1 (en) | 2016-06-02 | 2019-04-10 | West Pharma. Services Il, Ltd. | Three position needle retraction |
US11338090B2 (en) | 2016-08-01 | 2022-05-24 | West Pharma. Services IL, Ltd. | Anti-rotation cartridge pin |
EP3978047B1 (en) | 2016-08-01 | 2023-08-23 | West Pharma Services IL, Ltd | Partial door closure prevention spring |
KR102476516B1 (en) | 2016-12-21 | 2022-12-09 | 감브로 룬디아 아베 | A medical device system that includes an information technology infrastructure with secure cluster domains supporting external domains. |
US11045603B2 (en) | 2017-02-22 | 2021-06-29 | Insulet Corporation | Needle insertion mechanisms for drug containers |
CN110869072B (en) | 2017-05-30 | 2021-12-10 | 西部制药服务有限公司(以色列) | Modular drive mechanism for a wearable injector |
US10898656B2 (en) | 2017-09-26 | 2021-01-26 | Insulet Corporation | Needle mechanism module for drug delivery device |
US11147931B2 (en) | 2017-11-17 | 2021-10-19 | Insulet Corporation | Drug delivery device with air and backflow elimination |
CN114470420A (en) | 2017-12-22 | 2022-05-13 | 西氏医药包装(以色列)有限公司 | Syringe adapted for cartridges of different sizes |
WO2019209963A1 (en) | 2018-04-24 | 2019-10-31 | Deka Products Limited Partnership | Apparatus and system for fluid delivery |
US11241532B2 (en) | 2018-08-29 | 2022-02-08 | Insulet Corporation | Drug delivery system with sensor having optimized communication and infusion site |
KR102212231B1 (en) | 2019-03-07 | 2021-02-03 | 부산대학교 산학협력단 | Drug release estimation method for drug infusion pump and investigation device for drug infusion pump thereof |
KR102477255B1 (en) * | 2020-09-10 | 2022-12-14 | 이오플로우(주) | Method, apparatus and computer program product for determining the occurrence of occulusion in the inlet of a drug injection device |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3858581A (en) * | 1973-07-02 | 1975-01-07 | Dean Kamen | Medication injection device |
US4424720A (en) * | 1980-12-15 | 1984-01-10 | Ivac Corporation | Mechanism for screw drive and syringe plunger engagement/disengagement |
US4435173A (en) * | 1982-03-05 | 1984-03-06 | Delta Medical Industries | Variable rate syringe pump for insulin delivery |
DE3314664C2 (en) * | 1983-04-22 | 1985-02-21 | B. Braun Melsungen Ag, 3508 Melsungen | Procedure for triggering a pre-alarm in a pressure infusion apparatus |
US4562751A (en) * | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4678408A (en) * | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4685903A (en) * | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
EP0215104B1 (en) * | 1985-03-11 | 1992-08-26 | Strato Medical Corporation | Infusion device |
EP0285679A1 (en) * | 1987-04-04 | 1988-10-12 | B. Braun-SSC AG | Pressure infusion apparatus |
FR2639234B1 (en) * | 1988-11-21 | 1994-05-06 | Denance Raymond | INJECTION DEVICE FOR MEDICAL AND VETERINARY USE WHOSE STABILIZING SIGHT IS FOR SINGLE USE AND ACTUATES A MEANS AS A VALVE AT THE NEEDLE |
GB2229497B (en) * | 1989-03-10 | 1992-06-03 | Graseby Medical Ltd | Infusion pump |
US5244463A (en) * | 1991-12-06 | 1993-09-14 | Block Medical, Inc. | Programmable infusion pump |
US5254096A (en) * | 1992-09-23 | 1993-10-19 | Becton, Dickinson And Company | Syringe pump with graphical display or error conditions |
-
1995
- 1995-03-03 US US08/397,797 patent/US5647853A/en not_active Expired - Lifetime
-
1996
- 1996-02-20 WO PCT/US1996/002199 patent/WO1996027398A1/en active IP Right Grant
- 1996-02-20 CA CA002187094A patent/CA2187094C/en not_active Expired - Fee Related
- 1996-02-20 EP EP96906528A patent/EP0758253B1/en not_active Expired - Lifetime
- 1996-02-20 DE DE69625294T patent/DE69625294T2/en not_active Expired - Lifetime
- 1996-02-20 JP JP52687396A patent/JP4188414B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH09512472A (en) | 1997-12-16 |
DE69625294T2 (en) | 2004-01-29 |
CA2187094A1 (en) | 1996-09-12 |
US5647853A (en) | 1997-07-15 |
EP0758253A4 (en) | 1998-09-16 |
EP0758253B1 (en) | 2002-12-11 |
WO1996027398A1 (en) | 1996-09-12 |
JP4188414B2 (en) | 2008-11-26 |
DE69625294D1 (en) | 2003-01-23 |
EP0758253A1 (en) | 1997-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2187094C (en) | Rapid response occlusion detector for a medication infusion pump | |
US11654232B2 (en) | Infusion pump assembly | |
US10967137B2 (en) | Infusion pump assembly | |
US11173242B2 (en) | Infusion pump assembly | |
US4551133A (en) | Patient controlled medication infusion system | |
US5800387A (en) | Safety monitoring apparatus for a patient care system | |
US5078683A (en) | Programmable infusion system | |
US6362591B1 (en) | Method and apparatus for detection of occlusions | |
US10413682B2 (en) | Infusion pump methods, systems and apparatus | |
US5395321A (en) | Infusion apparatus capable of storing a plurality of accumulated infusion fluid volumes of the past | |
CA2795049C (en) | Infusion pump methods, systems and apparatus | |
US5840058A (en) | Infusion pump with disposable tubing and size indicating means | |
US20220387734A1 (en) | Infusion pump methods, systems and apparatus | |
Huey | Setting up and troubleshooting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130220 |